Medical/Pharmaceuticals
Global Healthcare Accreditation Welcomes Karin Jay as President of Global Strategy and Announces Renée-Marie Stephano's Transition to CEO
New Leadership Aims to Reinforce GHA's Position as the Foremost Authority in Medical and Well-being Travel Accreditation PALM BEACH GARDENS, Fla., Oct. 23, 2023 /PRNewswire/ -- Global Healthcare Accreditation (GHA), the esteemed authority in accreditation and certification with a specialized foc...
2023-10-23 18:00
1606
Sunvozertinib Demonstrates Best-in-Class Potential as a First-Line Treatment for EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer Patients
* Sunvozertinib monotherapy demonstrated superior efficacy and excellent safety in patients in the 1st line setting for advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 20 insertion (Exon20ins) mutations, achieving a confirmed objective...
2023-10-23 17:34
1357
InxMed Releases Data Demonstrating Ifebemtinib (IN10018) Trending Toward Survival Benefit at ESMO 2023
NANJING, China, Oct 22, 2023 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated on developing innovative therapies to overcome drug resistance for hard-to-treat solid tumors, announces that clinical data of Ifebemtinib (IN10018), a highly potent and selective oral i...
2023-10-23 08:00
1678
Jacobio Pharma Presents Clinical Results of Glecirasib in Combination with JAB-3312 at ESMO
* The ORR (objective response rate) and the DCR (disease control rate) in the frontline setting of glecirasib (KRAS G12C Inhibitor) in combination with JAB-3312 (SHP2 inhibitor) were 65.5% (38/58) and 100% respectively in all dose groups of advanced non-small cell lung cancer (NSCLC), among whi...
2023-10-22 15:05
2056
Zhimeng Biopharma CB03 Received Orphan Drug Designation from the US FDA - A Potassium Ion Channel Opener for Amyotrophic Lateral Sclerosis
SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced that one of its innovative small-molecule KCNQ2/3 selective opener compounds (CB03), developed for the treatment of amyotrophic lateral sclerosis (ALS), received orphan drug designation (ODD) from US F...
2023-10-20 21:00
1169
The 14th China (Taizhou) International Medical Expo Opens, Empowering the Growth of the Healthcare Industry
TAIZHOU, China, Oct. 20, 2023 /PRNewswire/ -- On October 19, the 14th China (Taizhou) International Medical Expo commenced at the China Medical City Convention Trade Center. Themed "Innovation Empowers the Construction of a Large Health Industry Ecosystem", this edition of the Medical Expo gather...
2023-10-20 17:17
1924
WuXi XDC Named Best CDMO Winner at 2023 World ADC Awards
SHANGHAI, Oct. 20, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract, Research, Development, and Manufacturing Organization (CRDMO) focused on the ADC and broader bioconjugate market, announced it has been named thewinner of the "Best Contract Development Manufacturing Organization (CDMO...
2023-10-20 16:00
1592
GC Genome to Present the Latest Lung Cancer Diagnostic Tool at ESMO 2023
- An innovative study of methylation markers and deep learning model enables precise lung cancer diagnosis. YONGIN, South Korea, Oct. 20, 2023 /PRNewswire/ -- GC Genome Corporation, a leading diagnostics company, today announced that it will present data showcasing deep learning algorithm utiliz...
2023-10-20 13:10
1294
NATIONAL UNIVERSITY HOSPITAL LAUNCHES GLOBAL FELLOWS ALLIANCE TO FOSTER INTERNATIONAL HEALTHCARE COLLABORATION
Fellows trained in NUH have emerged as leaders who are catalysing change in their respective fields upon their return home SINGAPORE, Oct. 19, 2023 /PRNewswire/ -- In line with its mission of being Singapore's leading university hospital, the National University Hospital (NUH) is launching its h...
2023-10-19 21:57
2127
NUS scientists develop innovative magnetic gel that heals diabetic wounds three times faster
First-of-its-kind cell therapy promotes wound healing, improves overall wound health and lowers risks of recurrence SINGAPORE, Oct. 19, 2023 /PRNewswire/ -- Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal. Such non-h...
2023-10-19 20:01
1577
World's first expo on health and healing! 2023 Sancheong World Traditional Medicine Anti-aging Expo ends with great success
- The world's first festival on health and healing, featuring a variety of content - Opportunity to enhance the competitiveness of K-anti-aging industry and show the excellence of traditional Korean medicine to the world GYEONGNAM, South Korea, Oct. 19, 2023 /PRNewswire/ -- The 2023 Sancheong W...
2023-10-19 20:00
1519
Phase 1a/1b Study Results of Akeso's PD-1/CTLA-4 Bispecific Antibody Published in Cell Reports Medicine, Highlighting Promising Efficacy in Solid Tumors Refractory/Relapsed to Standard Therapy
HONG KONG, Oct. 19, 2023 /PRNewswire/ -- Akeso (9926. HK) announced the publication of the phase 1a/1b first-in-human study (COMPASSION-01) evaluating cadonilimab (PD-1/CTLA-4 bispecific antibody) in patients with advanced solid tumors in Cell Reports Medicine, a sub-publication of Cell. Full ar...
2023-10-19 20:00
1452
InxMed Presents New Data at 14th Annual World ADC Highlighting Synergy of IN10018 with ADCs and Novel Stroma targeting pipeline
NANJING, China, Oct. 18, 2023 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnology company dedicated on developing innovative therapies to overcome treatment resistance for hard-to-treat solid tumors, is presenting preclinical data at 14th Annual World ADC Conference in San Diego regar...
2023-10-19 08:00
1549
SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023
* With a dedicated booth in the main exhibition hall, SK pharmteco solidifies its global position as the most trusted CDMO partner in the pharmaceutical industry * Appoints Chief Commercial Officer Andrew Fenny to strengthen its global marketing capabilities * Shortlisted as a finalist for ...
2023-10-18 20:00
1398
Complete Genomics Partners with Integrated DNA Technologies to Establish New Ecosystem of NGS Products
SAN JOSE, California, Oct. 18, 2023 /PRNewswire/ -- Complete Genomics, Inc., a
pioneering genomic sequencing company, today announced its partnership with
Integrated DNA Technologies (IDT),
2023-10-18 20:00
1540
WuXi XDC and HKSTP Join Forces to Promote Development of Bioconjugate Drug Industry in Hong Kong
* Hong Kong Science and Technology Parks Corporation (HKSTPC) and WuXi XDC signed a cooperation framework agreement to jointly promote the establishment of a contract research, development and manufacturing organization(CRDMO) value chain inHong Kong. * HKSTP Park companies will leverage WuXi...
2023-10-18 11:00
1526
First Patient Dosed in the Registrational Phase III Study of Olverembatinib in Treatment-Naïve Patients with Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)
SUZHOU, China and ROCKVILLE, Md., Oct. 17, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the registrational Phase III study (HQP1351AG...
2023-10-18 10:11
1472
Ubie's new Generative AI feature for doctors effortlessly summarizes patient findings and streamlines medical record documentation with a 90% User Satisfaction rate.
NEW YORK, Oct. 17, 2023 /PRNewswire/ -- Ubie
2023-10-17 23:00
1906
Congratulations to Sanyou Bio for achieving ISO9001 & IPMS certifications
SHANGHAI, Oct. 17, 2023 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd is pleased to announce inOctober 2023, we have obtained ISO 9001 and IPMS certifications. These certifications emphasize Sanyou's commitment to consistency, reliability, and accountability in our innovative biopharmaceuti...
2023-10-17 21:00
1497
Global Healthcare Startup Sky Labs Attracts Investments Totaling KRW 20.7 Billion in a Series C Round
- Major investors include Korea Development Bank (KDB), K2 Investment Partners, DEVSISTERS VENTURES, SJG Partners, and OPENWATER INVESTMENT - Distribution of 'CART BP,' a ring-type cuffless blood pressure monitor that enables continuous blood pressure measurement and monitoring 24/7, will be ful...
2023-10-17 20:00
1629
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
6217
